Please reach out to us If you feel that your values align with ours. We want to hear from you!
PsiOxus is a clinical-stage company redefining therapies for solid tumors to cure cancer patients. Our clinically validated, systemically dosed T-SIGn® viral vector platform delivers tumor localized production of combinations of protein therapeutics and synthetic payloads within solid tumors.
We have a rapidly expanding and advancing pipeline of novel monotherapy and combination products that have shown consistently strong safety profiles and increasing evidence of efficacy surrogates such as biomarkers. We aim to improve patients’ lives through novel therapies that unlock the power of the immune system.
We choose to fight cancer
alongside those patients who did not choose to be in that fight.
We choose to make a difference
because innovation and science can push the boundaries of what is possible.
We choose to work with honesty and integrity
because we recognise the important responsibilities that we have.
We choose to respect each other and our partners
because by working together we can achieve so much more than by working alone.
If you feel that your values align with ours, we want to hear from you!